Castrodale Louisa J, Beller Michael, Wilson Joseph F, Schantz Peter M, McManus Donald P, Zhang Li-Hua, Fallico Franc G, Sacco Frank D
Division of Applied Public Health Training, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Am J Trop Med Hyg. 2002 Mar;66(3):325-7. doi: 10.4269/ajtmh.2002.66.325.
Before 1999, clinical experience demonstrated that the sylvatic (or Northern) biotype of Echinococcus granulosus seen in Alaska produced fewer complications and serious sequelae than infection with the pastoral (or European) biotype found in other parts of the world. Two cases of E. granulosus with severe sequelae occurred in Alaska in 1999. The adverse outcomes could have been rare complications that are part of the clinical spectrum of disease caused by sylvatic cystic echinococcus, an indication that the sylvatic biotype, especially when affecting the liver, has potential for severe clinical consequences, or perhaps in one case, infection with a more virulent biotype of E. granulosus contracted during visits to Washington State.
1999年之前的临床经验表明,在阿拉斯加发现的细粒棘球绦虫的野生型(或北方型)生物型比在世界其他地区发现的畜牧型(或欧洲型)生物型感染产生的并发症和严重后遗症更少。1999年阿拉斯加出现了两例患有严重后遗症的细粒棘球绦虫病例。这些不良后果可能是野生型囊性棘球蚴病临床疾病谱中罕见的并发症,这表明野生型生物型,尤其是影响肝脏时,有产生严重临床后果的可能性,或者在其中一个病例中,可能是在访问华盛顿州期间感染了毒性更强的细粒棘球绦虫生物型。